Chondroitin Sulfate A-Adhering Plasmodium falciparum-Infected Erythrocytes Express Functionally Important Antibody Epitopes Shared by Multiple Variants
暂无分享,去创建一个
C. Lim | A. Lanzavecchia | M. Higgins | L. Hviid | N. Bernasconi | A. Salanti | P. Magistrado | M. Fried | P. Duffy | L. Barfod | N. Ndam | P. Khunrae | M. Dahlbäck | Firmine Viwami | J. Bruun | Tina Dobrilovic | Davis John | Lea K. Barfod
[1] Terrence J. Sejnowski,et al. Modelling Vesicular Release at Hippocampal Synapses , 2010, PLoS Comput. Biol..
[2] Thomas S. Rask,et al. Plasmodium falciparum Erythrocyte Membrane Protein 1 Diversity in Seven Genomes – Divide and Conquer , 2010, PLoS Comput. Biol..
[3] A. Salanti,et al. Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains? , 2010, Trends in parasitology.
[4] T. Theander,et al. Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies , 2010, Journal of molecular biology.
[5] B. Gamain,et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA , 2010, Proceedings of the National Academy of Sciences.
[6] L. Hviid. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development , 2010, Human vaccines.
[7] T. Theander,et al. The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs , 2010, Malaria Journal.
[8] A. Yadouleton,et al. Insecticide resistance status in Anopheles gambiae in southern Benin , 2010, Malaria Journal.
[9] M. Wahlgren,et al. Simultaneous transcription of duplicated var2csa gene copies in individual Plasmodium falciparum parasites , 2009, Genome Biology.
[10] T. Theander,et al. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites. , 2009, International journal for parasitology.
[11] Thomas Lavstsen,et al. Multiple var2csa-Type PfEMP1 Genes Located at Different Chromosomal Loci Occur in Many Plasmodium falciparum Isolates , 2009, PloS one.
[12] A. Lanzavecchia,et al. Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigens , 2009, Parasite immunology.
[13] T. Theander,et al. Induction of Adhesion-Inhibitory Antibodies against Placental Plasmodium falciparum Parasites by Using Single Domains of VAR2CSA , 2009, Infection and Immunity.
[14] T. Theander,et al. VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. , 2008, The Journal of infectious diseases.
[15] B. Gamain,et al. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites , 2008, Malaria Journal.
[16] P. Andersen,et al. Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA , 2008, Malaria Journal.
[17] Joseph D. Smith,et al. Evidence for Globally Shared, Cross-Reacting Polymorphic Epitopes in the Pregnancy-Associated Malaria Vaccine Candidate VAR2CSA , 2008, Infection and Immunity.
[18] Ole Lund,et al. Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA , 2008, PLoS pathogens.
[19] L. Hviid,et al. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria , 2007, Parasitology.
[20] Joseph Bockhorst,et al. Structural Polymorphism and Diversifying Selection on the Pregnancy Malaria Vaccine Candidate Var2csa , 2007 .
[21] S. Rogerson,et al. A novel flow cytometric phagocytosis assay of malaria-infected erythrocytes. , 2007, Journal of immunological methods.
[22] K. Marsh,et al. Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa. , 2007, The American journal of tropical medicine and hygiene.
[23] Samir N. Patel,et al. HIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites , 2007, PLoS medicine.
[24] L. Hviid,et al. Malaria in pregnancy: pathogenesis and immunity. , 2007, The Lancet. Infectious diseases.
[25] P. Andersen,et al. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA , 2007, Molecular microbiology.
[26] B. Gamain,et al. Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. , 2006, Microbes and infection.
[27] Ole Lund,et al. Epitope Mapping and Topographic Analysis of VAR2CSA DBL3X Involved in P. falciparum Placental Sequestration , 2006, PLoS pathogens.
[28] Stephen J Rogerson,et al. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. , 2006, Molecular and biochemical parasitology.
[29] L. Hviid,et al. Plasmodium falciparum Parasites Expressing Pregnancy-Specific Variant Surface Antigens Adhere Strongly to the Choriocarcinoma Cell Line BeWo , 2006, Infection and Immunity.
[30] Michael Lanzer,et al. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A , 2005, EMBO reports.
[31] T. Theander,et al. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. , 2005, The Journal of infectious diseases.
[32] L. Hviid,et al. Effects of Pregnancy and Intensity of Plasmodium falciparum Transmission on Immunoglobulin G Subclass Responses to Variant Surface Antigens , 2005, Infection and Immunity.
[33] J. Cox,et al. Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. , 2005, The Journal of infectious diseases.
[34] B. Gamain,et al. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. , 2005, The Journal of infectious diseases.
[35] P. Deloron,et al. Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates. , 2004, The Journal of infectious diseases.
[36] Thor G. Theander,et al. Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria , 2004, The Journal of experimental medicine.
[37] Joseph D. Smith,et al. Pregnancy-associated Malaria and the Prospects for Syndrome-specific Antimalaria Vaccines , 2004, The Journal of experimental medicine.
[38] Venkatachalam Udhayakumar,et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. , 2004, The American journal of tropical medicine and hygiene.
[39] M. Molyneux,et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection , 2004, The Lancet.
[40] T. Theander,et al. Geographical and Temporal Conservation of Antibody Recognition of Plasmodium falciparum Variant Surface Antigens , 2004, Infection and Immunity.
[41] Kevin Marsh,et al. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria , 2004, The Lancet.
[42] M. Fried,et al. Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated with Increased Birth Weight and the Gestational Age of Newborns , 2003, Infection and Immunity.
[43] Thomas Lavstsen,et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.
[44] L. Hviid,et al. Expression of Variant Surface Antigens by Plasmodium falciparum Parasites in the Peripheral Blood of Clinically Immune Pregnant Women Indicates Ongoing Placental Infection , 2003, Infection and Immunity.
[45] C. R.J.,et al. Statistics with Confidence (2nd ed.) , 2003 .
[46] M. Fried,et al. Analysis of CSA-binding parasites and antiadhesion antibodies. , 2002, Methods in molecular medicine.
[47] R. Leke,et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. , 2001, The Journal of infectious diseases.
[48] M. Valiyaveettil,et al. Structural Requirements for the Adherence ofPlasmodium falciparum-infected Erythrocytes to Chondroitin Sulfate Proteoglycans of Human Placenta* , 2000, The Journal of Biological Chemistry.
[49] T. Theander,et al. Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on Plasmodium falciparum-Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A1 , 2000, The Journal of Immunology.
[50] M. Smithson. Statistics with confidence , 2000 .
[51] M. Molyneux,et al. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. , 1999, The Journal of infectious diseases.
[52] T. Theander,et al. Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. , 1999, Cytometry.
[53] François Nosten,et al. Maternal antibodies block malaria , 1998, Nature.
[54] R. Coppel,et al. An alternative to serum for cultivation of Plasmodium falciparum in vitro. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[55] J. Aguiar,et al. Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. , 1992, The American journal of tropical medicine and hygiene.
[56] H. Groux,et al. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. , 1990, Research in immunology.
[57] R. Steketee,et al. RAPID SPONTANEOUS POSTPARTUM CLEARANCE OF PLASMODIUM FALCIPARUM PARASITAEMIA IN AFRICAN WOMEN , 1988, The Lancet.
[58] D. Warhurst,et al. SEPARATION OF MALARIA-INFECTED ERYTHROCYTES FROM WHOLE BLOOD: USE OF A SELECTIVE HIGH-GRADIENT MAGNETIC SEPARATION TECHNIQUE , 1981, The Lancet.